Schedule 13D ownership disclosure

Regencell Bioscience Holdings Ltd.

Security class unavailable · CUSIP: G7487R100

Event date: 2022-07-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,561,594
Percent of class
81.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-041491
Form type
SC 13D/A
Filer
Regencell (BVI) Ltd
CIK
CIK 1874958
Filed
Jul 26, 2022
Reporting period
Jul 25, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub